Greenbaum CJ, Long SA, Gitelman SE, Gaglia JL, et al. Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes. Diabetes 2026 Jan 21:db250777. doi: 10.2337/db25-0777.
PMID: 41564354